These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26497679)

  • 21. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
    Madeo A; Vinciguerra M; Lappano R; Galgani M; Gasperi-Campani A; Maggiolini M; Musti AM
    Oncogene; 2010 Feb; 29(7):978-91. PubMed ID: 19935718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tristetraprolin suppresses AHRR expression through mRNA destabilization.
    Lee HH; Kim WT; Kim DH; Park JW; Kang TH; Chung JW; Leem SH
    FEBS Lett; 2013 May; 587(10):1518-23. PubMed ID: 23583445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways.
    Lan T; Wu T; Chen C; Chen X; Hao J; Huang J; Wang L; Huang H
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):109-16. PubMed ID: 24508662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells.
    Zhao B; Yu W; Qian M; Simmons-Menchaca M; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1997 Jul; 19(3):180-90. PubMed ID: 9254885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin remodeling protein SMAR1 regulates NF-κB dependent Interleukin-8 transcription in breast cancer.
    Malonia SK; Yadav B; Sinha S; Lazennec G; Chattopadhyay S
    Int J Biochem Cell Biol; 2014 Oct; 55():220-6. PubMed ID: 25239884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells.
    Minet E; Michel G; Mottet D; Piret JP; Barbieux A; Raes M; Michiels C
    Exp Cell Res; 2001 Apr; 265(1):114-24. PubMed ID: 11281649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
    Leppänen T; Jalonen U; Korhonen R; Tuominen RK; Moilanen E
    Eur J Pharmacol; 2010 Feb; 628(1-3):220-5. PubMed ID: 19925787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
    Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
    Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
    Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cFos is critical for MCF-7 breast cancer cell growth.
    Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
    Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.
    Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS
    J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
    Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
    J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain.
    Cooper S; Ranger-Moore J; Bowden TG
    Mol Carcinog; 2005 Jun; 43(2):108-16. PubMed ID: 15791649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression.
    Maritz MF; van der Watt PJ; Holderness N; Birrer MJ; Leaner VD
    Biol Chem; 2011 May; 392(5):439-48. PubMed ID: 21417953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
    Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC
    Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
    Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6605-11. PubMed ID: 24377575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
    Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of proliferation of estrogen receptor‑positive MCF‑7 human breast cancer cells by tamoxifen through c‑Jun transcription factors.
    Xu Y; Zou ST; Zhu R; Li W; Gu CW; Wei SH; Xie JM; Wu HR
    Mol Med Rep; 2013 Apr; 7(4):1283-7. PubMed ID: 23404426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.